久久综合九色综合欧洲色-久久综合九色综合桃花-久久综合九色综合网站-久久综合久久综合九色-亚洲影院在线播放-亚洲永久视频

技術文章您現在的位置:首頁 > 技術文章 > Broadpharm提供可切割和不可切割Linker

Broadpharm提供可切割和不可切割Linker

更新時間:2023-08-28   點擊次數:922次

Antibody-Drug Conjugates (ADCs) are composed of a drug (payload) and antibody (mAbs) that are bound using linkages that are specifically designed to deliver the payload to the intended target environment. ADCs are designed to sparing healthy cells by targeting specific cancer types.

This article expands upon the linker information in the ADC Linker Technology in 2021 article. Specifically, the cleavable and non-cleavable categories of ADC linkers. Cleavable linkers use inherent properties of tumor cells for selective release of payloads from the ADCs. There are three commonly used mechanisms for cleavable linkers; protease-sensitive peptide linkers, acid sensitive hydrazone linkers, and glutathione-sensitive disulfide linkers.

Protease-sensitive cleavable linkers use the dominant proteases found in tumor cell lysosomes for recognition and cleavage of a specific peptide sequence in the linker. A commonly used ADC linker makes use of a valine-citrulline (vc) dipeptide, first discovered by Dubowchik et al., as an intracellular cleavage mechanism by cathepsin B.

diagram of adcetris
Figure 1. Adcetris with enzymatically cleavable val-cit linkage.

Acid-sensitive linkers use a lower pH in the endosomal (pH = 5-6) and lysosomal (pH = 4.8) compartments, in contrast to cytosol (pH = 7.4) to trigger hydrolysis of acid labile groups within a linker such as hydrazone.

Glutathione-sensitive linkers use higher concentrations of intracellular glutathione that in the plasma. This causes disulfide bridges to release the payload upon reduction by glutathione.

Cleavable linkers may also help with destroying cancer cell adjacent to their targets through a process referred to as "bystander effect". The bystander effect occurs when the payload is released near the targeted cancer cell, or a payload diffuses out of one cancer cell and then is absorbed by a second cancer cell.

Non-cleavable linkers only degrade when the anti-body degrades. Release of the payload occurs mainly in the lysosome after internalization of the ADC and degradation of both the antibody and linker. This may be an advantage since it could lead to a lower risk of systemic toxicity. Figure 2 shows an example of Kadcyla, which uses SMCC crosslinker as the non-cleavable linker.

diagram of kadcyla
Figure 2. Kadcyla, shown with the linker in green and the payload in orange, was designed with a non-cleavable linkage.

BroadPharm offers a wide array of different ADC Linkers, PEG Linkers to empower our customer's advanced research worldwide. These compounds feature great aqueous solubility, smart choice of PEG length, and a broad selection of functional groups to choose from.

Journal Reference:

1.Editorial Team, "FDA Grants Accelerated Approval for Sacituzumab Govitecan in Metastatic Triple-negative Breast Cancer", ADC Review (2020)

2.FDA Press Release, "FDA grants accelerated approval to loncastuximab tesirine-lpyl for large B-cell lymphoma", (2021)

3.Staudacher, Brown, "Antibody drug conjugates and bystander killing: is antigen-dependent internalisation required?", Br J Cancer 117, (2017): 1736-1742

    訂購咨詢

    靶點科技(北京)有限公司


靶點科技(北京)有限公司

靶點科技(北京)有限公司

地址:中關村生命科學園北清創意園2-4樓2層

© 2025 版權所有:靶點科技(北京)有限公司  備案號:京ICP備18027329號-2  總訪問量:302187  站點地圖  技術支持:化工儀器網  管理登陸

主站蜘蛛池模板: 91青青视频 | 高h全肉动漫在线观看免费 高h大街上羞耻露出调教 | 欧美在线黄 | 91麻豆久久久 | 国产成人福利在线视频下载 | 五月婷婷亚洲综合 | 日韩一区二区在线播放 | 日本欧美一区二区三区免费不卡 | 日韩精品视频免费网址 | 国产传媒果冻天美传媒 | 99re在线这里只有精品 | 中文字幕1区2区 | 亚洲日本天堂 | 国产高清一级毛片在线不卡 | 小毛片在线观看 | 亚洲高清一区二区三区四区 | 欧美成人看片黄a免费 | 99久久久国产精品免费播放器 | 91亚洲免费 | 精品国产亚洲一区二区三区 | 免费va在线观看 | 91亚瑟视频 | 久久99精品综合国产首页 | 99国产牛牛视频在线网站 | 在线天堂新版在线观看 | 国产自产c区 | 9966国产精品视频 | 九九热精品视频在线 | 天天影视亚洲 | 一级做a爰片久久毛片免费看 | 国内外成人免费在线视频 | 青青青青青国产免费观看 | 欧美在线视频一区二区三区 | 羞羞视频在线观看 | 日本男女网站 | 最新亚洲人成网站在线影院 | 亚洲人成在线免费观看 | 日本黄色网站在线观看 | 日韩av成人 | 九九热国产视频 | 国产成人精品2021欧美日韩 |